PCA062 in pCAD-positive Tumors.

Clinical trial NCT02375958 · COMPLETED

Trial details

NCT number: NCT02375958
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Head & Neck Cancer Esophageal Cancer

Start date: 2015-04-15
Primary completion: 2018-07-17
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.